p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis
about
Mechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disordersModulation of actin dynamics by Rac1 to target cognitive functionProtein prenylation and synaptic plasticity: implications for Alzheimer's diseaseThe Beta-amyloid protein of Alzheimer's disease: communication breakdown by modifying the neuronal cytoskeletonAmyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's diseaseRho family GTPases: key players in neuronal development, neuronal survival, and neurodegenerationp21-Activated kinase inhibitors: a patent reviewPAK in Alzheimer disease, Huntington disease and X-linked mental retardationDendritic Spines: Similarities with Protrusions and Adhesions in Migrating CellsPivotal role of the RanBP9-cofilin pathway in Aβ-induced apoptosis and neurodegeneration.Omega-3 fatty acids and dementia.PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and AβGenetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's diseaseTransgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.Gastrointestinal hormones/neurotransmitters and growth factors can activate P21 activated kinase 2 in pancreatic acinar cells by novel mechanismsMolecular mechanisms of neurodegeneration in Alzheimer's disease.Isoprenoids, small GTPases and Alzheimer's disease.CDK5 is essential for soluble amyloid β-induced degradation of GKAP and remodeling of the synaptic actin cytoskeletonProbing the biology of Alzheimer's disease in mice.Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro.Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease.Fragile X mental retardation protein: from autism to neurodegenerative disease.PAK1 as a therapeutic target.Increased actin polymerization and stabilization interferes with neuronal function and survival in the AMPKγ mutant Loechrig.The Interface between Cytoskeletal Aberrations and Mitochondrial Dysfunction in Alzheimer's Disease and Related DisordersChemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity.FLIM FRET Visualization of Cdc42 Activation by Netrin-1 in Embryonic Spinal Commissural Neuron Growth ConesThe protection of acetylcholinesterase inhibitor on β-amyloid-induced the injury of neurite outgrowth via regulating axon guidance related genes expression in neuronal cells.C-terminal turn stability determines assembly differences between Aβ40 and Aβ42A novel Rac1 GAP splice variant relays poly-Ub accumulation signals to mediate Rac1 inactivation.1-42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death.Involvement of betaPIX in angiotensin II-induced migration of vascular smooth muscle cellsInvolvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease.Neuronal Rho GEFs in synaptic physiology and behavior.Impaired geranylgeranyltransferase-I regulation reduces membrane-associated Rho protein levels in aged mouse brain.Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis.Structural and functional alterations in amyloid-β precursor protein induced by amyloid-β peptides.Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias.Dietary fatty acids and the aging brain.
P2860
Q24632757-CEA6C146-AF64-4C0E-8D91-A14AF80E4EDFQ26820813-261C9BDE-1D4E-4AF9-BE88-D470912EF2A1Q26858942-C62F4C78-AF6F-405C-A91B-7067BB648B26Q26864818-6702EA35-EBCF-4FE7-8692-AAFFAF7DFC0DQ27012950-59413D15-A05F-4826-BA62-3BF19D17B234Q27027490-F5624230-8D61-44AE-8439-A625BD380B7BQ28261519-50323051-1072-4A88-BC13-2E9E577E8820Q28279479-5C64C4F2-773E-44F9-B651-A931FA8956A8Q30435838-EA9B3D54-A0D2-42F6-81DD-BF5EAB1ED3A8Q30524239-1AD7C0B5-9BA0-460B-BE50-5B7B7BDB07F8Q33602402-64A2B168-CC7B-4243-AF38-74D2BE759E5FQ33605706-8E9DB8CE-E8D0-46BC-8FCD-CDA57EA19678Q33707872-CDE15316-3B10-4BE4-AD8F-3D70C6A89111Q33804587-6641A146-309E-49E8-BA61-492B982CABFFQ33809148-79740A6F-0750-44B4-8A3E-52372FFD5429Q33871297-A0B7C14F-C648-450C-91E1-41DEA444EC54Q33915441-18940C86-3CC4-47B6-805B-C9FBC55BE2C9Q33988231-90ADD422-9CE1-4683-AA58-863C549ABB4DQ34206962-A7EDA26E-9589-4827-8E90-4C550E41D88BQ34454073-EE6C8932-4C11-4861-B58D-B87E68B32E41Q34609941-FBCB0A30-8753-4347-927A-C14C4288D22BQ35027999-3F27480F-57E2-4CBE-B119-A191D5982C0CQ35077291-899A4393-7A12-432E-9458-DD96B2B850ACQ35108164-FF7D8F99-E341-4F2B-848F-CBCEE34A97E4Q35108197-5D129A6B-255E-4B5B-8CDD-291906A7673DQ35542857-2165A900-B598-4E8B-BAB9-8B106FD55A83Q35607881-17453585-3AB7-4AE1-AA83-6A3080B7F7C5Q36092322-3D764D93-9484-426D-BAF3-A9379F8D632BQ36358021-45B81303-6059-4A4B-A139-951C683FA87EQ36517962-4FDACD21-B6AF-4639-A58E-576C5053970CQ36587936-1BAC5ECD-8C45-44A2-BBF6-44CFCC5D73FBQ36593861-9796B349-33B5-4916-85C6-E59597039144Q37250677-0481AD3B-3619-47DA-A8DA-C91B08010F5AQ37257096-CB45F4B2-A40D-49D4-B4E9-5D50B919FBB8Q37589859-DA8A4070-71F8-4F92-8DF9-5F5B13E993F8Q37722638-27BE0886-549F-4CA1-858E-C1EC0FF64E77Q37722680-4F893B41-1B3C-4AA1-BAFF-18AA5DB02A41Q37727192-BDEE7899-B526-4DB0-8EFE-742FCA0D74EBQ37790804-060E2D4C-FDF0-43FF-B2B7-EB70D652C4C5Q37811077-D5999CFF-0064-4841-80D0-8BE12A25F0A7
P2860
p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis
description
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2008
@ast
im Mai 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/05/16)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/05/16)
@nl
наукова стаття, опублікована в травні 2008
@uk
name
p21-activated kinase-aberrant ...... Alzheimer disease pathogenesis
@ast
p21-activated kinase-aberrant ...... Alzheimer disease pathogenesis
@en
p21-activated kinase-aberrant ...... Alzheimer disease pathogenesis
@nl
type
label
p21-activated kinase-aberrant ...... Alzheimer disease pathogenesis
@ast
p21-activated kinase-aberrant ...... Alzheimer disease pathogenesis
@en
p21-activated kinase-aberrant ...... Alzheimer disease pathogenesis
@nl
prefLabel
p21-activated kinase-aberrant ...... Alzheimer disease pathogenesis
@ast
p21-activated kinase-aberrant ...... Alzheimer disease pathogenesis
@en
p21-activated kinase-aberrant ...... Alzheimer disease pathogenesis
@nl
P2093
P2860
P3181
P356
P1476
p21-activated kinase-aberrant ...... Alzheimer disease pathogenesis
@en
P2093
Fusheng Yang
Greg M. Cole
James E. Hansen
Oliver J. Ubeda
Qiu-Lan Ma
Richard H. Weisbart
Sally A. Frautschy
Walter Beech
P2860
P304
14132–14143
P3181
P356
10.1074/JBC.M708034200
P407
P577
2008-05-16T00:00:00Z